PestleMedicine Explained

Rimegepant

VYDURA is used to treat and prevent migraine attacks in adults. It contains rimegepant, which blocks the activity of a substance in the body called calcitonin gene-related peptide (CGRP).

Active ingredient: rimegepant (as sulfate)

Official leaflet

Key facts

  1. It can stop an active migraine attack and can reduce the number of migraine attacks when taken preventively.
  2. The maximum dose is one 75 mg oral lyophilisate per day.
  3. Stop taking it and tell your doctor straight away if you have signs of an allergic reaction, which can occur several days after taking it.
  4. It is not for children and adolescents under 18 years of age.
  5. Some medicines should be avoided with VYDURA, and others mean you should not take it more than once every 48 hours.

Who should not take rimegepant

The leaflet says not to take it if any of these apply to you.

  • if you are allergic to rimegepant or any of the other ingredients of this medicine

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • if you have severe liver problems
  • if you have reduced kidney function or are on kidney dialysis
  • not to be given to children and adolescents under 18 years of age because it has not yet been studied in this age group

How to take rimegepant

  • To prevent migraine, take one 75 mg oral lyophilisate every other day.
  • To treat a migraine attack, take one 75 mg oral lyophilisate as needed, not more than once daily. The maximum daily dose is one per day.
  • Use dry hands, peel back the foil of one blister and gently remove the oral lyophilisate without pushing it through the foil. Place it on or under the tongue where it will dissolve; no drink or water is needed.
  • It can be taken with or without food or water. Do not store the oral lyophilisate outside the blister for future use.
  • If you miss a preventive dose, take the next dose at the usual time. Do not take a double dose.

Side effects

Get medical help straight away

The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.

  • Signs of an allergic reaction, such as severe rash or shortness of breath (uncommon, may affect up to 1 in 100 people)
  • Signs of a severe allergic reaction known as anaphylaxis, such as swelling of tongue, mouth or face, trouble swallowing or breathing, throat tightness, or hoarseness (uncommon, may affect up to 1 in 100 people)

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Common

Up to 1 in 10 people

  • Nausea

Uncommon

Up to 1 in 100 people

  • Allergic reactions, including anaphylaxis

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

It is preferable to avoid VYDURA during pregnancy as its effects in pregnant women are not known, so ask your doctor or pharmacist for advice. If you are breast-feeding or planning to, talk to your doctor or pharmacist; you and your doctor should decide if you will use it.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • Tell your doctor or pharmacist about any other medicines you are taking, have recently taken or might take
  • Medicines to avoid: itraconazole and clarithromycin (fungal or bacterial infections)
  • Medicines to avoid: ritonavir and efavirenz (HIV infections)
  • Medicines to avoid: bosentan (high blood pressure)
  • Medicines to avoid: St. John's wort (herbal remedy for depression)
  • Medicines to avoid: phenobarbital (epilepsy)
  • Medicines to avoid: rifampicin (tuberculosis)
  • Medicines to avoid: modafinil (narcolepsy)
  • Do not take VYDURA more than once every 48 hours with fluconazole and erythromycin (fungal or bacterial infections)
  • Do not take VYDURA more than once every 48 hours with diltiazem, quinidine and verapamil (abnormal heart rhythm, chest pain (angina) or high blood pressure)
Show 1 moreShow fewer
  • Do not take VYDURA more than once every 48 hours with cyclosporin (prevents organ rejection after a transplant)

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Vydura 75mg Oral Lyophilisate
Product licence
PLPI457631452
Leaflet dated
Checked against the leaflet
Automated check
2 of 2 side effects matched to the wording of the leaflet

Other makers of rimegepant publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.